Signal processing for measurement of physiological analytes
First Claim
1. One or more microprocessors comprising programming to control operating a sensing device to obtain two or more active signals, wherein (i) said sensing device is in operative contact with an analyte, (ii) said sensing device obtains an active signal from the analyte, and (iii) said active signal is specifically related to analyte amount or concentration present in a biological system;
- assigning a fractional weight to each of said two or more active signals based on when the respective active signals were generated with respect to one another;
determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and
performing a calibration step that converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system.
3 Assignments
0 Petitions

Accused Products

Abstract
A method is provided for continually or continuously measuring the concentration of target chemical analytes present in a biological system, and processing analyte-specific signals to obtain a measurement value that is closely correlated with the concentration of the target chemical analyte in the biological system. One important application of the invention involves a method for signal processing in a system for monitoring blood glucose values.
724 Citations
Method of Calibrating an Analyte-Measurement Device, and Associated Methods, Devices and Systems | ||
Patent #
US 20110004084A1
Filed 09/17/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 7,909,775 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 7,917,186 B2
Filed 11/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,914,465 B2
Filed 02/08/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,774 B2
Filed 02/13/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 7,892,183 B2
Filed 07/03/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,914,450 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,875,047 B2
Filed 01/25/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,778 B2
Filed 04/20/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,777 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,901,365 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and system for providing sensor redundancy | ||
Patent #
US 7,946,985 B2
Filed 12/29/2006
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,955,261 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,933,639 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,938,787 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 7,928,850 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 7,920,906 B2
Filed 03/09/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,925,321 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Universal Models for Predicting Glucose Concentration in Humans | ||
Patent #
US 20110160555A1
Filed 07/31/2009
|
Current Assignee
Srinivasan Rajaraman, Andrei Gribok, Adiwinata Gani, Jacques Reifman
|
Original Assignee
Srinivasan Rajaraman, Andrei Gribok, Adiwinata Gani, Jacques Reifman
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,959,569 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,935,057 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 7,927,274 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,959,582 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy | ||
Patent #
US 7,985,330 B2
Filed 12/29/2006
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,010,174 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,007,446 B2
Filed 10/19/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,988,644 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and System for Providing Sensor Redundancy | ||
Patent #
US 20110218489A1
Filed 04/13/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,998,071 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,005,525 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,000,901 B2
Filed 08/09/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,986,986 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,005,524 B2
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 7,976,492 B2
Filed 08/06/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,016,774 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Methods and apparatus for lancet actuation | ||
Patent #
US 7,981,056 B2
Filed 06/18/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Device and method for variable speed lancet | ||
Patent #
US 7,976,476 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Tissue penetration device | ||
Patent #
US 7,981,055 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,979,104 B2
Filed 05/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties | ||
Patent #
US 7,988,645 B2
Filed 05/03/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,052,601 B2
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,066,639 B2
Filed 06/04/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,060,173 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,062,231 B2
Filed 10/11/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Extraction device, analyzer, extraction method, and analysis method | ||
Patent #
US 8,046,043 B2
Filed 11/16/2005
|
Current Assignee
Sysmex Corporation
|
Original Assignee
Sysmex Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030038A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 7,811,231 B2
Filed 12/26/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Health Management Devices and Methods | ||
Patent #
US 20100331646A1
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 7,715,893 B2
Filed 12/03/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 7,766,829 B2
Filed 11/04/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030485A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,826,981 B2
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and Apparatus for Determining Temperatures in a Fluid Analyte System | ||
Patent #
US 20100319436A1
Filed 06/23/2010
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Bayer Healthcare LLC
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,797,028 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,778,680 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Closed Loop Medicament Pump | ||
Patent #
US 20090048584A1
Filed 09/26/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Closed Loop Medicament Pump | ||
Patent #
US 20090043291A1
Filed 09/26/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090099435A1
Filed 11/13/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 7,519,408 B2
Filed 11/17/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,583,990 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 7,591,801 B2
Filed 02/26/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,599,726 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 7,620,438 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 7,640,048 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD OF CALIBRATING OF AN ANALYTE-MEASUREMENT DEVICE, AND ASSOCIATED METHODS, DEVICES AND SYSTEMS | ||
Patent #
US 20080081969A1
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and System for Providing Sensor Redundancy | ||
Patent #
US 20080161664A1
Filed 12/29/2006
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Closed-Loop Method for Controlling Insulin Infusion | ||
Patent #
US 20080188796A1
Filed 04/04/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Diabetes care host-client architecture and data management system | ||
Patent #
US 20060010098A1
Filed 06/06/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Extraction device, analyzer, extraction method, and analysis method | ||
Patent #
US 20060116563A1
Filed 11/16/2005
|
Current Assignee
Sysmex Corporation
|
Original Assignee
Sysmex Corporation
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,123,700 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 8,123,686 B2
Filed 03/01/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method of calibrating of an analyte-measurement device, and associated methods, devices and systems | ||
Patent #
US 8,116,840 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy | ||
Patent #
US 8,114,268 B2
Filed 08/21/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,079,960 B2
Filed 10/10/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,519 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
RF tag on test strips, test strip vials and boxes | ||
Patent #
US 8,115,635 B2
Filed 11/24/2009
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,520 B2
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for determining the point of hydration and proper time to apply potential to a glucose sensor | ||
Patent #
US 8,114,269 B2
Filed 12/28/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,103,456 B2
Filed 01/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing leak detection in data monitoring and management systems | ||
Patent #
US 8,112,240 B2
Filed 04/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,128,562 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,149,117 B2
Filed 08/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,150,488 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 8,140,142 B2
Filed 04/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,157,748 B2
Filed 01/10/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 8,160,669 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,160,671 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,162,853 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,167,801 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,170,803 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,187,183 B2
Filed 10/11/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,195,265 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,421 B2
Filed 07/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,423 B2
Filed 12/14/2010
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Pelikan Technologies Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,206,297 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,206,317 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,206,319 B2
Filed 08/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,211,037 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,216,139 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration | ||
Patent #
US 8,216,138 B1
Filed 10/23/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,216,154 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,221,334 B2
Filed 12/22/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
RF tag on test strips, test strip vials and boxes | ||
Patent #
US 8,223,021 B2
Filed 11/24/2009
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,226,891 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,229,536 B2
Filed 05/27/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,229,534 B2
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for blood glucose monitoring and alert delivery | ||
Patent #
US 8,229,535 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,233,959 B2
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,233,958 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,239,166 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,235,915 B2
Filed 12/18/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,249,684 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,251,906 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,251,921 B2
Filed 06/10/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,257,259 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal data artifacts in a glucose sensor data stream | ||
Patent #
US 8,260,393 B2
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,260,558 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for fluid injection | ||
Patent #
US 8,262,614 B2
Filed 06/01/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,265,725 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for body fluid sampling with hybrid actuation | ||
Patent #
US 8,267,870 B2
Filed 05/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,275,437 B2
Filed 03/23/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,280,475 B2
Filed 02/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,282,576 B2
Filed 09/29/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 8,282,550 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,282,577 B2
Filed 06/15/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,282,549 B2
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,285,354 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,287,453 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,287,495 B2
Filed 10/10/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,290,559 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,290,560 B2
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,290,561 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,290,562 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,292,810 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method of manufacturing a fluid sampling device with improved analyte detecting member configuration | ||
Patent #
US 8,296,918 B2
Filed 08/23/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,298,184 B2
Filed 10/11/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,311,749 B2
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,321,149 B2
Filed 06/29/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,332,008 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,333,710 B2
Filed 10/05/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,421 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,419 B2
Filed 10/04/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,420 B2
Filed 03/24/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,343,075 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,346,338 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
RF tag on test strips, test strip vials and boxes | ||
Patent #
US 8,358,210 B2
Filed 11/24/2009
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,360,991 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,360,992 B2
Filed 11/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 8,362,904 B2
Filed 04/18/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,366,637 B2
Filed 12/03/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,369,919 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,372,016 B2
Filed 09/30/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,374,667 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,382,682 B2
Filed 02/06/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,382,683 B2
Filed 03/07/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,386,004 B2
Filed 09/07/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,388,551 B2
Filed 05/27/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
RF tag on test strips, test strip vials and boxes | ||
Patent #
US 8,390,455 B2
Filed 11/24/2009
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,396,528 B2
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Health data management device | ||
Patent #
US 8,401,873 B2
Filed 05/29/2008
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Bayer Healthcare LLC
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,403,864 B2
Filed 05/01/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,412,301 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,414,503 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for processing sensor data | ||
Patent #
US 8,417,312 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,423,113 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,428,678 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,428,679 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,430,828 B2
Filed 01/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,435,190 B2
Filed 01/19/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,435,179 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth | ||
Patent #
US 8,439,872 B2
Filed 04/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,442,610 B2
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,444,560 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,452,368 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,456,301 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,461,985 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,469,886 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing data management in data monitoring system | ||
Patent #
US 8,471,714 B2
Filed 12/30/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,473,220 B2
Filed 01/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,474,397 B2
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,475,373 B2
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,491,500 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,491,474 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,496,601 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system having an alert | ||
Patent #
US 8,497,777 B2
Filed 04/15/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing continuous calibration of implantable analyte sensors | ||
Patent #
US 8,506,482 B2
Filed 02/07/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Close proximity communication device and methods | ||
Patent #
US 8,509,107 B2
Filed 11/01/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing peak detection circuitry for data communication systems | ||
Patent #
US 8,512,246 B2
Filed 03/15/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,512,239 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 8,514,086 B2
Filed 08/30/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and device for providing offset model based calibration for analyte sensor | ||
Patent #
US 8,532,935 B2
Filed 07/16/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measurement device and methods using RFID | ||
Patent #
US 8,542,122 B2
Filed 01/17/2013
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring and management system and methods therefor | ||
Patent #
US 8,543,183 B2
Filed 12/23/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,548,553 B2
Filed 06/22/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,556,829 B2
Filed 01/27/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,560,038 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,560,037 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,562,545 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,848 B2
Filed 05/07/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,562,558 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,571,808 B2
Filed 01/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with analyte sensing | ||
Patent #
US 8,574,168 B2
Filed 03/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 8,574,895 B2
Filed 12/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,579,816 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,579,831 B2
Filed 10/06/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor calibration management | ||
Patent #
US 8,583,205 B2
Filed 04/16/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 8,585,591 B2
Filed 07/10/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,588,882 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for customizing delivery of sensor data | ||
Patent #
US 8,591,455 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,593,287 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,593,109 B2
Filed 11/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Health management devices and methods | ||
Patent #
US 8,597,188 B2
Filed 06/20/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,597,575 B2
Filed 07/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,600,681 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for determining the point of hydration and proper time to apply potential to a glucose sensor | ||
Patent #
US 8,608,924 B2
Filed 12/16/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,612,163 B2
Filed 08/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,611,978 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Health monitor | ||
Patent #
US 8,617,069 B2
Filed 06/20/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and apparatus for determining temperatures in a fluid analyte system | ||
Patent #
US 8,617,381 B2
Filed 06/23/2010
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Bayer Healthcare LLC
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,622,903 B2
Filed 05/25/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,622,905 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,622,930 B2
Filed 07/18/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,202,231 B2
Filed 04/23/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for evaluating analyte sensor response characteristics | ||
Patent #
US 8,635,046 B2
Filed 06/22/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,636,673 B2
Filed 12/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing data communication in data monitoring and management systems | ||
Patent #
US 8,638,220 B2
Filed 05/23/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sampling module device and method | ||
Patent #
US 8,641,643 B2
Filed 04/27/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 8,641,644 B2
Filed 04/23/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,647,269 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data management in data monitoring system | ||
Patent #
US 8,653,977 B2
Filed 06/21/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,657,745 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,657,747 B2
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,663,109 B2
Filed 03/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 8,665,091 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 8,668,656 B2
Filed 12/31/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,672,845 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,676,287 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,676,513 B2
Filed 06/21/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing sensor redundancy | ||
Patent #
US 8,679,016 B2
Filed 04/13/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Tissue penetration device | ||
Patent #
US 8,679,033 B2
Filed 06/16/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 8,682,615 B2
Filed 08/04/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method of calibrating an analyte-measurement device, and associated methods, devices and systems | ||
Patent #
US 8,684,930 B2
Filed 06/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,690,796 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,700,117 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for analyte measurement test time | ||
Patent #
US 8,652,831 B2
Filed 03/26/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 8,702,624 B2
Filed 01/29/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Mitigating single point failure of devices in an analyte monitoring system and methods thereof | ||
Patent #
US 8,710,993 B2
Filed 11/21/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor calibration management | ||
Patent #
US 8,718,739 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors | ||
Patent #
US 8,718,958 B2
Filed 03/12/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated, University of Virginia Patent Foundation
|
Transcutaneous analyte sensor | ||
Patent #
US 8,721,545 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electric lancet actuator | ||
Patent #
US 8,721,671 B2
Filed 07/06/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,721,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
Dex Com Inc.
|
Analyte monitoring system having an alert | ||
Patent #
US 8,730,058 B2
Filed 07/29/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,731,630 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing contextual based medication dosage determination | ||
Patent #
US 8,732,188 B2
Filed 02/15/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Close proximity communication device and methods | ||
Patent #
US 8,737,259 B2
Filed 08/05/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing analyte sensor calibration | ||
Patent #
US 8,744,547 B2
Filed 07/09/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,747,315 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,750,955 B2
Filed 11/02/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,758,323 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,761,856 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,771,187 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 8,771,183 B2
Filed 02/16/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,774,888 B2
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Body fluid sampling device with a capacitive sensor | ||
Patent #
US 8,784,335 B2
Filed 07/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,006 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,008 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,788,007 B2
Filed 03/08/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,790,260 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,955 B2
Filed 06/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,795,177 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,801,611 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,801,612 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,801,610 B2
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,808,228 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for penetrating tissue | ||
Patent #
US 8,808,201 B2
Filed 01/15/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,808,182 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 8,812,072 B2
Filed 04/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,812,073 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Displays for a medical device | ||
Patent #
US 8,816,862 B2
Filed 08/19/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,821,400 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Printable hydrogels for biosensors | ||
Patent #
US 8,828,203 B2
Filed 05/20/2005
|
Current Assignee
Sanofi-Aventis SA
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing analyte sensor calibration | ||
Patent #
US 8,834,366 B2
Filed 07/31/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,843,187 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method for penetrating tissue | ||
Patent #
US 8,845,549 B2
Filed 12/02/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,845,550 B2
Filed 12/03/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,845,536 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,858,434 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device for channeling fluid and methods of use | ||
Patent #
US 8,880,138 B2
Filed 09/30/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,273 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,905,945 B2
Filed 03/29/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Don Alden, Dirk Boecker, Dominique M. Freeman
|
Transcutaneous analyte sensor | ||
Patent #
US 8,915,849 B2
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,926,561 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,926,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Multi-function analyte test device and methods therefor | ||
Patent #
US 8,930,203 B2
Filed 02/03/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,933,664 B2
Filed 11/25/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,945,910 B2
Filed 06/19/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods | ||
Patent #
US 8,965,477 B2
Filed 04/14/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,965,476 B2
Filed 04/18/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,986,209 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,989,833 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 8,993,331 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,000,929 B2
Filed 11/22/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 9,008,743 B2
Filed 04/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,020,572 B2
Filed 09/10/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensors and methods of use | ||
Patent #
US 9,031,630 B2
Filed 11/01/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 9,034,639 B2
Filed 06/26/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 9,035,767 B2
Filed 05/30/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,039,975 B2
Filed 12/02/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detecting false hypoglycemic conditions | ||
Patent #
US 9,050,041 B2
Filed 05/21/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,055,901 B2
Filed 09/14/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,060,719 B2
Filed 12/13/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 9,066,709 B2
Filed 03/17/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electronic devices having integrated reset systems and methods thereof | ||
Patent #
US 9,069,536 B2
Filed 10/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,072,842 B2
Filed 07/31/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,078,608 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 9,088,452 B2
Filed 01/31/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 9,089,294 B2
Filed 01/16/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,089,678 B2
Filed 05/21/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,095,290 B2
Filed 02/27/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and apparatus for determining temperatures in a fluid analyte system | ||
Patent #
US 9,097,650 B2
Filed 12/02/2013
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Bayer Healthcare LLC
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,107,623 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 9,113,828 B2
Filed 07/09/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,125,548 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 9,135,402 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,143,569 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low pain penetrating member | ||
Patent #
US 9,144,401 B2
Filed 12/12/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for processing sensor data | ||
Patent #
US 9,149,234 B2
Filed 06/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,149,219 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 9,149,233 B2
Filed 06/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,177,456 B2
Filed 06/10/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system having an alert | ||
Patent #
US 9,178,752 B2
Filed 04/25/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Close proximity communication device and methods | ||
Patent #
US 9,184,875 B2
Filed 04/25/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Fluid analyte meter | ||
Patent #
US 9,189,598 B2
Filed 03/09/2013
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Bayer Healthcare LLC
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,186,468 B2
Filed 01/14/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Displays for a medical device | ||
Patent #
US 9,186,113 B2
Filed 08/11/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,192,328 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 9,204,827 B2
Filed 04/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,211,377 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,220,449 B2
Filed 07/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Displays for a medical device | ||
Patent #
US 9,226,714 B2
Filed 01/08/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Body fluid sampling module with a continuous compression tissue interface surface | ||
Patent #
US 9,226,699 B2
Filed 11/09/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Error detection in critical repeating data in a wireless sensor system | ||
Patent #
US 9,226,701 B2
Filed 04/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 9,248,267 B2
Filed 07/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,247,901 B2
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Printable hydrogel for biosensors | ||
Patent #
US 9,261,476 B2
Filed 04/01/2014
|
Current Assignee
Sanofi-Aventis SA
|
Original Assignee
Sanofi S.A.
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,282,925 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Mitigating single point failure of devices in an analyte monitoring system and methods thereof | ||
Patent #
US 9,289,179 B2
Filed 04/11/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing real time analyte sensor calibration with retrospective backfill | ||
Patent #
US 9,310,230 B2
Filed 06/24/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 9,314,194 B2
Filed 01/11/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,314,196 B2
Filed 09/07/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof | ||
Patent #
US 9,317,656 B2
Filed 11/21/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,314,198 B2
Filed 04/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,314,195 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,320,461 B2
Filed 09/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor calibration management | ||
Patent #
US 9,320,462 B2
Filed 05/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,323,898 B2
Filed 11/15/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, devices and methods for managing glucose levels | ||
Patent #
US 9,326,709 B2
Filed 03/09/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Alarm characterization for analyte monitoring devices and systems | ||
Patent #
US 9,326,707 B2
Filed 11/10/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data management in data monitoring system | ||
Patent #
US 9,332,944 B2
Filed 01/31/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 9,339,238 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,339,612 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods of use | ||
Patent #
US 9,339,217 B2
Filed 11/21/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for a variable user interface | ||
Patent #
US 9,351,680 B2
Filed 10/14/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,351,668 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,364,173 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Cam drive for managing disposable penetrating member actions with a single motor and motor and control system | ||
Patent #
US 9,375,169 B2
Filed 01/29/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for powering an electronic device | ||
Patent #
US 9,380,971 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for analyte detecting device | ||
Patent #
US 9,386,944 B2
Filed 04/10/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing analyte sensor calibration | ||
Patent #
US 9,398,872 B2
Filed 08/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,420,965 B2
Filed 07/01/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,427,532 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,427,183 B2
Filed 07/12/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 9,446,194 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electronic devices having integrated reset systems and methods thereof | ||
Patent #
US 9,465,420 B2
Filed 06/26/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Multi-rate analyte sensor data collection with sample rate configurable signal processing | ||
Patent #
US 9,474,475 B1
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,483,608 B2
Filed 05/20/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Predictive calibration | ||
Patent #
US 9,486,171 B2
Filed 03/15/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method for penetrating tissue | ||
Patent #
US 9,498,160 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,498,155 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same | ||
Patent #
US 9,532,737 B2
Filed 02/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 9,538,946 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Displays for a medical device | ||
Patent #
US 9,549,694 B2
Filed 11/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 9,560,993 B2
Filed 12/20/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 9,561,000 B2
Filed 12/10/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,574,914 B2
Filed 03/03/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
NONINVASIVE BLOOD SUGAR MEASUREMENT DEVICE | ||
Patent #
US 20170065231A1
Filed 09/04/2015
|
Current Assignee
Goldensunda Technology Co. Ltd.
|
Original Assignee
Goldensunda Technology Co. Ltd.
|
Transcutaneous analyte sensor | ||
Patent #
US 9,603,557 B2
Filed 05/13/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 9,615,780 B2
Filed 04/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Model based variable risk false glucose threshold alarm prevention mechanism | ||
Patent #
US 9,622,691 B2
Filed 10/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,625,413 B2
Filed 05/19/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable vital sign sensor | ||
Patent #
US 9,629,560 B2
Filed 03/29/2016
|
Current Assignee
Thomas Jefferson University
|
Original Assignee
Thomas Jefferson University
|
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites | ||
Patent #
US 9,636,450 B2
Filed 02/15/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Udo Hoss, Gary A. Stafford
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,649,069 B2
Filed 06/29/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,649,057 B2
Filed 05/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing analyte sensor calibration | ||
Patent #
US 9,662,056 B2
Filed 05/22/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and apparatus for determining temperatures in a fluid analyte system | ||
Patent #
US 9,664,644 B2
Filed 06/24/2015
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Ascensia Diabetes Care Holdings AG
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Temporary suspension for closed-loop medicament therapy | ||
Patent #
US 9,669,160 B2
Filed 07/30/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,669,162 B2
Filed 03/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 9,675,290 B2
Filed 10/29/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 9,693,688 B2
Filed 07/16/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sampling module device and method | ||
Patent #
US 9,694,144 B2
Filed 12/03/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and methods for processing sensor data | ||
Patent #
US 9,717,449 B2
Filed 01/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,724,021 B2
Filed 12/08/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods | ||
Patent #
US 9,724,029 B2
Filed 02/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,724,045 B1
Filed 04/06/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 9,730,584 B2
Filed 02/10/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor calibration management | ||
Patent #
US 9,730,623 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Alarm characterization for analyte monitoring devices and systems | ||
Patent #
US 9,730,650 B2
Filed 01/15/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,737,249 B2
Filed 06/17/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 9,741,139 B2
Filed 08/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 9,743,863 B2
Filed 06/01/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Mitigating single point failure of devices in an analyte monitoring system and methods thereof | ||
Patent #
US 9,743,872 B2
Filed 02/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data management in data monitoring system | ||
Patent #
US 9,750,440 B2
Filed 04/12/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,750,439 B2
Filed 04/08/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,750,441 B2
Filed 08/15/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,750,460 B2
Filed 04/14/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,775,543 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,775,553 B2
Filed 10/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Continuous analyte measurement systems and systems and methods for implanting them | ||
Patent #
US 9,795,326 B2
Filed 07/22/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,795,334 B2
Filed 07/09/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,795,747 B2
Filed 06/02/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,797,880 B2
Filed 10/11/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,801,545 B2
Filed 07/30/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 9,801,571 B2
Filed 09/16/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 9,801,577 B2
Filed 06/07/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,802,007 B2
Filed 11/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 9,804,150 B2
Filed 03/24/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 9,814,416 B2
Filed 12/13/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 9,814,428 B2
Filed 08/22/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,820,684 B2
Filed 06/03/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Close proximity communication device and methods | ||
Patent #
US 9,831,985 B2
Filed 09/29/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insulin pump based expert system | ||
Patent #
US 9,833,177 B2
Filed 02/24/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,176 B2
Filed 07/12/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 9,839,395 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Body fluid sampling device with capacitive sensor | ||
Patent #
US 9,839,386 B2
Filed 06/12/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensors and methods of use | ||
Patent #
US 9,844,329 B2
Filed 05/06/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors | ||
Patent #
US 9,882,660 B2
Filed 04/30/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated, University of Virginia Patent Foundation
|
System and methods for processing analyte sensor data | ||
Patent #
US 9,895,089 B2
Filed 05/20/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Textile Fabric For Placing On The Skin And/Or A Wound Of A Patient, And Transdermal Patch And Arrangement Consisting Of A Transdermal Patch And An Evaluation Unit | ||
Patent #
US 20180049667A1
Filed 03/04/2016
|
Current Assignee
Fresenius Medical Care Deutschland GmbH
|
Original Assignee
Fresenius Medical Care Deutschland GmbH
|
Systems and methods for processing sensor data | ||
Patent #
US 9,901,307 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data | ||
Patent #
US 9,907,492 B2
Filed 09/18/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,907,502 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Model based variable risk false glucose threshold alarm prevention mechanism | ||
Patent #
US 9,913,619 B2
Filed 04/13/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,918,668 B2
Filed 03/09/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing analyte monitoring and therapy management system accuracy | ||
Patent #
US 9,936,910 B2
Filed 04/25/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,937,293 B2
Filed 08/19/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,937,298 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 9,949,639 B2
Filed 06/27/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,949,678 B2
Filed 02/16/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 9,962,091 B2
Filed 01/06/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for detecting occlusions in an infusion pump | ||
Patent #
US 9,962,486 B2
Filed 11/02/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,968,302 B2
Filed 04/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems | ||
Patent #
US 9,968,306 B2
Filed 10/21/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods | ||
Patent #
US 9,980,669 B2
Filed 11/07/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,002,233 B2
Filed 05/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system having an alert | ||
Patent #
US 10,009,244 B2
Filed 10/30/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Advanced step therapy delivery for an ambulatory infusion pump and system | ||
Patent #
US 10,016,559 B2
Filed 10/28/2014
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Clinical variable determination | ||
Patent #
US 10,016,561 B2
Filed 03/15/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,031,002 B2
Filed 12/02/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Low pain penetrating member | ||
Patent #
US 10,034,628 B2
Filed 12/20/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,039,881 B2
Filed 07/07/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,045,720 B2
Filed 10/15/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump with blood glucose alert delay | ||
Patent #
US 10,052,049 B2
Filed 08/08/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Sensor fault detection using analyte sensor data pattern comparison | ||
Patent #
US 10,076,285 B2
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, devices and methods for managing glucose levels | ||
Patent #
US 10,078,380 B2
Filed 04/07/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods of use | ||
Patent #
US 10,082,493 B2
Filed 04/29/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for providing offset model based calibration for analyte sensor | ||
Patent #
US 10,089,446 B2
Filed 09/03/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration of analyte measurement system | ||
Patent #
US 10,092,229 B2
Filed 06/29/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 10,111,608 B2
Filed 04/14/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing continuous calibration of implantable analyte sensors | ||
Patent #
US 10,117,614 B2
Filed 09/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for detecting false hypoglycemic conditions | ||
Patent #
US 10,117,606 B2
Filed 06/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,119,956 B2
Filed 10/27/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 10,123,752 B2
Filed 11/10/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Dropout detection in continuous analyte monitoring data during data excursions | ||
Patent #
US 10,132,793 B2
Filed 08/20/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical devices and methods | ||
Patent #
US 10,136,816 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Mitigating single point failure of devices in an analyte monitoring system and methods thereof | ||
Patent #
US 10,136,847 B2
Filed 08/24/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,143,409 B2
Filed 10/27/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,172,518 B2
Filed 04/13/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 10,178,954 B2
Filed 05/09/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 10,182,751 B2
Filed 06/26/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 10,188,334 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Closed loop control and signal attenuation detection | ||
Patent #
US 10,188,794 B2
Filed 06/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 10,194,868 B2
Filed 11/10/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Accuracy of continuous glucose sensors | ||
Patent #
US 10,194,850 B2
Filed 07/14/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data management in data monitoring system | ||
Patent #
US 10,206,611 B2
Filed 08/23/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US RE47,315 E1
Filed 06/30/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems including vial adapter for fluid transfer | ||
Patent #
US 10,258,736 B2
Filed 01/04/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,261,069 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,278,580 B2
Filed 06/09/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods | ||
Patent #
US 10,285,632 B2
Filed 07/25/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Closed loop control system interface and methods | ||
Patent #
US 10,328,201 B2
Filed 10/30/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable vital sign sensor | ||
Patent #
US 10,335,043 B2
Filed 11/17/2016
|
Current Assignee
RTM Vitals Signs LLC
|
Original Assignee
Thomas Jefferson University
|
Dropout detection in continuous analyte monitoring data during data excursions | ||
Patent #
US 10,345,291 B2
Filed 11/16/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Fluid analyte meter system | ||
Patent #
US 10,347,371 B2
Filed 10/08/2015
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Original Assignee
Ascensia Diabetes Care Holdings AG
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 10,349,874 B2
Filed 08/31/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in medical communication system | ||
Patent #
US 10,349,877 B2
Filed 04/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Correction factor testing using frequent blood glucose input | ||
Patent #
US 10,357,607 B2
Filed 12/08/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and method for integration of insulin pumps and continuous glucose monitoring | ||
Patent #
US 10,357,606 B2
Filed 03/13/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,403,012 B2
Filed 07/18/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Implantable vital sign sensor | ||
Patent #
US 10,413,200 B2
Filed 03/29/2016
|
Current Assignee
Thomas Jefferson University
|
Original Assignee
Thomas Jefferson University
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 10,429,250 B2
Filed 03/26/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Noise rejection methods and apparatus for sparsely sampled analyte sensor data | ||
Patent #
US 10,433,773 B1
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 10,456,091 B2
Filed 11/05/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor calibration management | ||
Patent #
US 10,463,288 B2
Filed 08/11/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,463,310 B2
Filed 09/07/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical devices and methods | ||
Patent #
US 10,492,685 B2
Filed 08/31/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 10,506,982 B2
Filed 05/22/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,537,678 B2
Filed 12/16/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,555,695 B2
Filed 07/02/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,561,354 B2
Filed 07/02/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for switching between closed loop and open loop control of an ambulatory infusion pump | ||
Patent #
US 10,569,016 B2
Filed 12/29/2016
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Implantable vital sign sensor | ||
Patent #
US 10,602,936 B2
Filed 08/08/2017
|
Current Assignee
Thomas Jefferson University
|
Original Assignee
Thomas Jefferson University
|
Analyte sensor | ||
Patent #
US 10,602,968 B2
Filed 09/10/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,610,141 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,610,642 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,617,296 B2
Filed 01/07/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,624,568 B2
Filed 08/13/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,634,662 B2
Filed 11/05/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 10,653,317 B2
Filed 01/10/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,653,344 B2
Filed 11/19/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for training users of ambulatory medical devices | ||
Patent #
US 10,653,834 B2
Filed 11/09/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dropout detection in continuous analyte monitoring data during data excursions | ||
Patent #
US 10,656,139 B2
Filed 07/08/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and devices for analyte monitoring calibration | ||
Patent #
US 10,660,554 B2
Filed 03/08/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and systems for simulating glucose response to simulated actions | ||
Patent #
US 10,675,405 B2
Filed 12/04/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,682,084 B2
Filed 05/07/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insulin delivery apparatuses capable of bluetooth data transmission | ||
Patent #
US 10,685,749 B2
Filed 12/28/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,722,162 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 10,750,952 B2
Filed 03/26/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 10,772,572 B2
Filed 10/25/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 10,786,185 B2
Filed 01/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing data processing and control in a medical communication system | ||
Patent #
US 10,820,841 B2
Filed 08/09/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous analyte measurement systems and systems and methods for implanting them | ||
Patent #
US 10,827,954 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 10,827,980 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,835,162 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data | ||
Patent #
US 10,842,420 B2
Filed 03/02/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for mitigating risk in automated medicament dosing | ||
Patent #
US 10,864,322 B2
Filed 12/20/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Multi-rate analyte sensor data collection with sample rate configurable signal processing | ||
Patent #
US 10,874,336 B2
Filed 10/12/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Displays for a medical device | ||
Patent #
US 10,881,355 B2
Filed 06/15/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients | ||
Patent #
US 6,024,699 A
Filed 03/13/1998
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
HealthWare Corporation
|
Method and device for predicting physiological values | ||
Patent #
US 6,180,416 B1
Filed 09/30/1998
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Cygnus Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,175,752 B1
Filed 04/30/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Signal processing for measurement of physiological analysis | ||
Patent #
US 6,233,471 B1
Filed 05/11/1999
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Cygnus Inc.
|
Analyte sensor and holter-type monitor system and method of using the same | ||
Patent #
US 6,248,067 B1
Filed 02/05/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Device and method of calibrating and testing a sensor for in vivo measurement of an analyte | ||
Patent #
US 6,275,717 B1
Filed 06/23/1998
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Original Assignee
Elan Corporation PLC
|
Networked system for interactive communications and remote monitoring of drug delivery | ||
Patent #
US 6,270,455 B1
Filed 11/30/1998
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Methods for monitoring a physiological analyte | ||
Patent #
US 6,299,578 B1
Filed 09/18/1997
|
Current Assignee
Animas Technologies LLC
|
Original Assignee
Cygnus Inc.
|
Microprocessors for use in a device for predicting physiological values | ||
Patent #
US 6,326,160 B1
Filed 09/27/1999
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Cygnus Inc.
|
Device for the detection of analyte and administration of a therapeutic substance | ||
Patent #
US 6,014,577 A
Filed 11/20/1997
|
Current Assignee
Abbott Laboratories Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Method of sampling substances using alternating polarity of iontophoretic current | ||
Patent #
US 6,023,629 A
Filed 11/10/1997
|
Current Assignee
Animas Technologies LLC
|
Original Assignee
Cygnus Inc.
|
Urine testing apparatus capable of simply and accurately measuring a partial urine to indicate urinary glucose value of total urine | ||
Patent #
US 6,021,339 A
Filed 09/28/1998
|
Current Assignee
NEC Corporation
|
Original Assignee
NEC Corporation
|
Implantable sensor and system for in vivo measurement and control of fluid constituent levels | ||
Patent #
US 6,049,727 A
Filed 04/03/1998
|
Current Assignee
Animas Corporation
|
Original Assignee
Animas Corporation
|
Sensor controlled analysis and therapeutic delivery system | ||
Patent #
US 6,059,736 A
Filed 02/24/1998
|
Current Assignee
Robert Tapper
|
Original Assignee
Robert Tapper
|
Electrochemical sensor and integrity tests therefor | ||
Patent #
US 6,088,608 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Implantable sensor and system for measurement and control of blood constituent levels | ||
Patent #
US 6,122,536 A
Filed 06/23/1998
|
Current Assignee
Animas Corporation
|
Original Assignee
Animas Corporation
|
Electrochemical analyte | ||
Patent #
US 6,134,461 A
Filed 03/04/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Monitoring of physiological analytes | ||
Patent #
US 6,144,869 A
Filed 05/11/1999
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Cygnus Inc.
|
Personal computer card for collection of real-time biological data | ||
Patent #
US 6,159,147 A
Filed 10/15/1998
|
Current Assignee
VectraCor Inc.
|
Original Assignee
QRS DIAGNOSTICS LLC
|
Implantable sensor and system for measurement and control of blood constituent levels | ||
Patent #
US 5,995,860 A
Filed 07/06/1995
|
Current Assignee
Animas Corporation
|
Original Assignee
Thomas Jefferson University
|
Method for the iontophoretic non-invasive determination of the in vivo concentration level of glucose | ||
Patent #
US 5,730,714 A
Filed 09/26/1994
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers | ||
Patent #
US 5,722,397 A
Filed 06/06/1995
|
Current Assignee
Nitto Denko Corporation
|
Original Assignee
Altia Technology
|
Chemical signal-impermeable mask | ||
Patent #
US 5,735,273 A
Filed 09/12/1995
|
Current Assignee
Animas Technologies LLC
|
Original Assignee
Cygnus Inc.
|
Apparatus and method for non-invasive blood analyte measurement | ||
Patent #
US 5,752,512 A
Filed 05/10/1995
|
Current Assignee
Massachusetts Institute of Technology
|
Original Assignee
Massachusetts Institute of Technology
|
Device and method for sampling of substances using alternating polarity | ||
Patent #
US 5,771,890 A
Filed 06/24/1994
|
Current Assignee
Animas Technologies LLC
|
Original Assignee
Cygnus Inc.
|
Analyte-controlled liquid delivery device and analyte monitor | ||
Patent #
US 5,807,375 A
Filed 11/02/1995
|
Current Assignee
Elan Corporation PLC
|
Original Assignee
Elan Medical Technologies Ireland Ltd.
|
Analyte-controlled liquid delivery device and analyte monitor | ||
Patent #
US 5,800,420 A
Filed 12/19/1996
|
Current Assignee
Elan Corporation PLC
|
Original Assignee
Elan Medical Technologies Ireland Ltd.
|
Analyte-controlled liquid delivery device and analyte monitor | ||
Patent #
US 5,820,622 A
Filed 12/18/1996
|
Current Assignee
Elan Pharma International Limited
|
Original Assignee
Elan Medical Technologies Ireland Ltd.
|
Method of measuring chemical concentration iontophoretically using impermeable mask | ||
Patent #
US 5,827,183 A
Filed 10/29/1997
|
Current Assignee
Animas Technologies LLC
|
Original Assignee
Cygnus Inc.
|
Diabetes management system and method for controlling blood glucose | ||
Patent #
US 5,822,715 A
Filed 04/18/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Robust accurate non-invasive analyte monitor | ||
Patent #
US 5,830,132 A
Filed 02/03/1997
|
Current Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Original Assignee
Mark R. Robinson
|
Reliable noninvasive measurement of blood gases | ||
Patent #
US 5,630,413 A
Filed 08/12/1994
|
Current Assignee
Sandia Corporation
|
Original Assignee
Sandia Corporation
|
Glucose monitoring system | ||
Patent #
US 5,497,772 A
Filed 11/19/1993
|
Current Assignee
MANN ALFRED E. FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Analytical system for monitoring a substance to be analyzed in patient-blood | ||
Patent #
US 5,507,288 A
Filed 05/03/1995
|
Current Assignee
Boehringer Mannheim GmbH
|
Original Assignee
Boehringer Mannheim GmbH
|
Systematic wavelength selection for improved multivariate spectral analysis | ||
Patent #
US 5,435,309 A
Filed 08/10/1993
|
Current Assignee
Sandia Corporation
|
Original Assignee
Sandia Corporation
|
Integrated system for biological fluid constituent analysis | ||
Patent #
US 5,443,080 A
Filed 12/22/1993
|
Current Assignee
AMERICARE DIAGNOSTICS INC.
|
Original Assignee
AMERICATE TRANSTECH INC.
|
Method and apparatus for non-invasive phase sensitive measurement of blood glucose concentration | ||
Patent #
US 5,448,992 A
Filed 06/01/1993
|
Current Assignee
SUNSHINE MEDICAL INSTRUMENTS INC.
|
Original Assignee
SUNSHINE MEDICAL INSTRUMENTS INC.
|
Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers | ||
Patent #
US 5,458,140 A
Filed 11/15/1993
|
Current Assignee
Nitto Denko Corporation
|
Original Assignee
Non-Invasive Monitoring Company
|
Medical communication system | ||
Patent #
US 5,462,051 A
Filed 08/31/1994
|
Current Assignee
Omron Healthcare Company Limited
|
Original Assignee
Colin Corporation
|
Device for iontophoretic non-invasive sampling or delivery of substances | ||
Patent #
US 5,279,543 A
Filed 04/30/1992
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Reliable noninvasive measurement of blood gases | ||
Patent #
US 5,355,880 A
Filed 07/06/1992
|
Current Assignee
Sandia Corporation
|
Original Assignee
Sandia Corporation
|
Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance | ||
Patent #
US 5,362,307 A
Filed 10/04/1991
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Method for the direct measurement of at least one chemical parameter of skin using a biosensor | ||
Patent #
US 5,250,419 A
Filed 08/13/1991
|
Current Assignee
LOreal SA
|
Original Assignee
LOreal SA
|
Non-invasive method and apparatus for measuring blood glucose concentration | ||
Patent #
US 5,267,152 A
Filed 10/26/1990
|
Current Assignee
Yoon O. Kim, Won S. Yang
|
Original Assignee
Yoon O. Kim, Won S. Yang
|
Non-invasive measurement of blood glucose | ||
Patent #
US 5,086,229 A
Filed 06/27/1990
|
Current Assignee
Futrex Inc.
|
Original Assignee
Futrex Inc.
|
Apparatus and method for noninvasive blood glucose monitoring | ||
Patent #
US 5,139,023 A
Filed 06/02/1989
|
Current Assignee
Theratech Inc.
|
Original Assignee
STANLEY RESEARCH FOUNDATION, Theratech Inc.
|
Noninvasive blood glucose measuring device | ||
Patent #
US 5,140,985 A
Filed 10/21/1991
|
Current Assignee
Jon M. Schroeder, Joseph F. Long
|
Original Assignee
Jon M. Schroeder, Joseph F. Long
|
Method and apparatus for non-invasively monitoring plasma glucose levels | ||
Patent #
US 5,036,861 A
Filed 01/11/1990
|
Current Assignee
William R. Kennedy, Carter R. Anderson, Walter L. Sembrowich
|
Original Assignee
William R. Kennedy, Carter R. Anderson, Walter L. Sembrowich
|
Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor | ||
Patent #
US 5,063,081 A
Filed 08/15/1990
|
Current Assignee
i STAT Corporation
|
Original Assignee
i STAT Corporation
|
Method and apparatus for determination of chemical species in body fluid | ||
Patent #
US 5,076,273 A
Filed 11/13/1990
|
Current Assignee
Sudormed Incorporated
|
Original Assignee
Sudor Partners
|
Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids | ||
Patent #
US 4,975,581 A
Filed 06/21/1989
|
Current Assignee
The United States of America As Represented By The Secretary of Agriculture
|
Original Assignee
The University of New Mexico
|
Complete glucose monitoring system with an implantable, telemetered sensor module | ||
Patent #
US 4,703,756 A
Filed 05/06/1986
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Personal physiological monitor | ||
Patent #
US 4,509,531 A
Filed 07/28/1982
|
Current Assignee
Avionics Specialties Inc.
|
Original Assignee
Teledyne Instruments Incorporated
|
Diabetic insulin alarm system | ||
Patent #
US 4,178,916 A
Filed 09/26/1977
|
Current Assignee
Elger W. Mcnamara
|
Original Assignee
Elger W. Mcnamara
|
30 Claims
-
1. One or more microprocessors comprising programming to control operating a sensing device to obtain two or more active signals, wherein (i) said sensing device is in operative contact with an analyte, (ii) said sensing device obtains an active signal from the analyte, and (iii) said active signal is specifically related to analyte amount or concentration present in a biological system;
-
assigning a fractional weight to each of said two or more active signals based on when the respective active signals were generated with respect to one another; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration step that converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. One or more microprocessors comprising Programming to control operating a sensing device to obtain two or more active signals, wherein (i) said sensing device is in operative contact with an analyte, (ii) said sensing device obtains an active signal from the analyte, and (iii) said active signal is specifically related to analyte amount or concentration present in a biological system:
-
assigning a fractional weight to each of said two or more active signals; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration step that converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system. wherein the sensing device uses an iontophoretic current to extract the analyte from the biological system.
-
-
11. A method for measuring an analyte amount or concentration present in a biological system, said method comprising:
-
obtaining an active signal from the analyte, wherein said active signal is related to analyte concentration; repeating said obtaining to provide two or more active signals; assigning a fractional weight to each of said two or more active signals based on when the respective active signals were generated with respect to one another; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration step which converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 20, 21, 22, 24, 25, 27, 28, 29, 30)
-
-
19. A method for measuring an analyte amount or concentration present in a biological system, said method comprising:
-
obtaining an active signal from the analyte, wherein said active signal is related to analyte concentration; repeating said obtaining to provide two or more active signals; assigning a fractional weight to each of said two or more active signals; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration step which converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system, wherein the first collection reservoir is in contact with the skin or mucosal surface of the biological system and the analyte is extracted using an iontophoretic current applied to said skin or mucosal surface.
-
-
23. A method for measuring an analyte amount or concentration present in a biological system, said method comprising:
-
obtaining an active signal from the analyte, wherein said active signal is related to analyte concentration; repeating said obtaining to provide two or more active signals; assigning a fractional weight to each of said two or more active signals; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration step which converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system, wherein obtaining the active signal comprises a baseline background subtraction method to remove background noise from the active signal.
-
-
26. A method for measuring an analyte amount or concentration present in a biological system, said method comprising:
-
obtaining an active signal from the analyte, wherein said active signal is related to analyte concentration; repeating said obtaining to provide two or more active signals; assigning a fractional weight to each of said two or more active signals; determining a weighted signal that accounts for the different contributions of each of said two or more active signals and their associated fractional weights; and performing a calibration which converts the weighted signal to a measurement value indicative of the amount or concentration of analyte present in the biological system, wherein the calibration entails the use of a neural network algorithm that correlates each weighted signal with a measurement value indicative of the concentration of analyte present in the biological system.
-
1 Specification
This application is a continuation, pursuant 35 U.S.C. §120, of U.S. patent application Ser. No. 09/794,783, filed Feb. 27, 2001, now U.S. Pat. No. 6,595,919, which is a continuation, pursuant 35 U.S.C. §120, of U.S. patent application Ser. No. 09/309,728, filed May 11, 1999, now U.S. Pat. No. 6,233,471, which claims priority, under 35 USC §119(e)(1), to provisional patent application Ser. No. 60/085,344, filed May 13, 1998, and which applications are incorporated herein by reference with their entireties.
The invention relates generally to methods for continually or continuously measuring the concentration of target chemical analytes present in a biological system. More particularly, the invention relates to methods for processing signals obtained during measurement of physiological analytes. One important application of the invention involves a method for monitoring blood glucose concentrations.
A number of diagnostic tests are routinely performed on humans to evaluate the amount or existence of substances present in blood or other body fluids. These diagnostic tests typically rely on physiological fluid samples removed from a subject, either using a syringe or by pricking the skin. One particular diagnostic test entails self-monitoring of blood glucose levels by diabetics.
Diabetes is a major health concern, and treatment of the more severe form of the condition, Type I (insulin-dependent) diabetes, requires one or more insulin injections per day. Insulin controls utilization of glucose or sugar in the blood and prevents hyperglycemia which, if left uncorrected, can lead to ketosis. On the other hand, improper administration of insulin therapy can result in hypoglycemic episodes, which can cause coma and death. Hyperglycemia in diabetics has been correlated with several long-term effects of diabetes, such as heart disease, atherosclerosis, blindness, stroke, hypertension and kidney failure.
The value of frequent monitoring of blood glucose as a means to avoid or at least minimize the complications of Type I diabetes is well established. Patients with Type II (non-insulin-dependent) diabetes can also benefit from blood glucose monitoring in the control of their condition by way of diet and exercise.
Conventional blood glucose monitoring methods generally require the drawing of a blood sample (e.g., by fingerprick) for each test, and a determination of the glucose level using an instrument that reads glucose concentrations by electrochemical or calorimetric methods. Type I diabetics must obtain several fingerprick blood glucose measurements each day in order to maintain tight glycemic control. However, the pain and inconvenience associated with this blood sampling, along with the fear of hypoglycemia, has led to poor patient compliance, despite strong evidence that tight control dramatically reduces long-term diabetic complications. In fact, these considerations can often lead to an abatement of the monitoring process by the diabetic. See, e.g., The Diabetes Control and Complications Trial Research Group (1993) New Engl. J. Med. 329:977-1036.
Recently, various methods for determining the concentration of blood analytes without drawing blood have been developed. For example, U.S. Pat. No. 5,267,152 to Yang et al. describes a noninvasive technique of measuring blood glucose concentration using near-IR radiation diffuse-reflection laser spectroscopy. Similar near-IR spectrometric devices are also described in U.S. Pat. No. 5,086,229 to Rosenthal et al. and U.S. Pat. No. 4,975,581 to Robinson et al.
U.S. Pat. Nos. 5,139,023 to Stanley et al., and 5,443,080 to D'"'"'Angelo et al. describe transdermal blood glucose monitoring devices that rely on a permeability enhancer (e.g., a bile salt) to facilitate transdermal movement of glucose along a concentration gradient established between interstitial fluid and a receiving medium. U.S. Pat. No. 5,036,861 to Sembrowich describes a passive glucose monitor that collects perspiration through a skin patch, where a cholinergic agent is used to stimulate perspiration secretion from the eccrine sweat gland. Similar perspiration collection devices are described in U.S. Pat. No. 5,076,273 to Schoendorfer and U.S. Pat. No. 5,140,985 to Schroeder.
In addition, U.S. Pat. No. 5,279,543 to Glikfeld et al. describes the use of iontophoresis to noninvasively sample a substance through skin into a receptacle on the skin surface. Glikfeld teaches that this sampling procedure can be coupled with a glucose-specific biosensor or glucose-specific electrodes in order to monitor blood glucose. Finally, International Publication No. WO 96/00110, published Jan. 4, 1996, describes an iontophoretic apparatus for transdermal monitoring of a target substance, wherein an iontophoretic electrode is used to move an analyte into a collection reservoir and a biosensor is used to detect the target analyte present in the reservoir.
The present invention provides a method for continually or continuously measuring the concentration of an analyte present in a biological system. The method entails continually or continuously detecting an analyte from the biological system and deriving a raw signal therefrom, wherein the raw signal is related to the analyte concentration. A number of signal processing steps are then carried out in order to convert the raw signal into an initial signal output that is indicative of an analyte amount. The converted signal is then further converted into a value indicative of the concentration of analyte present in the biological system.
The raw signal can be obtained using any suitable sensing methodology including, for example, methods which rely on direct contact of a sensing apparatus with the biological system; methods which extract samples from the biological system by invasive, minimally invasive, and non-invasive sampling techniques, wherein the sensing apparatus is contacted with the extracted sample; methods which rely on indirect contact of a sensing apparatus with the biological system; and the like. In preferred embodiments of the invention, methods are used to extract samples from the biological sample using minimally invasive or non-invasive sampling techniques. The sensing apparatus used with any of the above-noted methods can employ any suitable sensing element to provide the raw signal including, but not limited to, physical, chemical, electrochemical, photochemical, spectrophotometric, polarimetric, colorimetric, radiometric, or like elements. In preferred embodiments of the invention, a biosensor is used which comprises an electrochemical sensing element.
In one particular embodiment of the invention, the raw signal is obtained using a transdermal sampling system that is placed in operative contact with a skin or mucosal surface of the biological system. The sampling system transdermally extracts the analyte from the biological system using any appropriate sampling technique, for example, iontophoresis. The transdermal sampling system is maintained in operative contact with the skin or mucosal surface of the biological system to provide for such continual or continuous analyte measurement.
The analyte can be any specific substance or component that one is desirous of detecting and/or measuring in a chemical, physical, enzymatic, or optical analysis. Such analytes include, but are not limited to, amino acids, enzyme substrates or products indicating a disease state or condition, other markers of disease states or conditions, drugs of abuse, therapeutic and/or pharmacologic agents, electrolytes, physiological analytes of interest (e.g., calcium, potassium, sodium, chloride, bicarbonate (CO2), glucose, urea (blood urea nitrogen), lactate, hematocrit, and hemoglobin), lipids, and the like. In preferred embodiments, the analyte is a physiological analyte of interest, for example glucose, or a chemical that has a physiological action, for example a drug or pharmacological agent.
Accordingly, it is an object of the invention to provide a method for continually or continuously measuring an analyte present in a biological system, wherein raw signals are obtained from a suitable sensing apparatus, and then subjected to signal processing is techniques. More particularly, the raw signals undergo a data screening method in order to eliminate outlier signals and/or poor (incorrect) signals using a predefined set of selection criteria. In addition, or alternatively, the raw signal can be converted in a conversion step which (i) removes or corrects for background information, (ii) integrates the raw signal over a sensing time period, (iii) performs any process which converts the raw signal from one signal type to another, or (iv) performs any combination of steps (i), (ii) and/or (iii). In preferred embodiments, the conversion step entails a baseline background subtraction method to remove background from the raw signal and an integration step. In other embodiments, the conversion step can be tailored for use with a sensing device that provides both active and reference (blank) signals; wherein mathematical transformations are used to individually smooth active and reference signals, and/or to subtract a weighted reference (blank) signal from the active signal. In still further embodiments, the conversion step includes correction functions which account for changing conditions in the biological system and/or the biosensor system (e.g., temperature fluctuations in the biological system, temperature fluctuations in the sensor element, skin conductivity fluctuations, or combinations thereof). The result of the conversion step is an initial signal output which provides a value which can be correlated with the concentration of the target analyte in the biological sample.
It is also an object of the invention to provide a signal processing calibration step, wherein the raw or initial signals obtained as described above are converted into an analyte-specific value of known units to provide an interpretation of the signal obtained from the sensing device. The interpretation uses a mathematical transformation to model the relationship between a measured response in the sensing device and a corresponding analyte-specific value. Such mathematical transformations can entail the use of linear or nonlinear regressions, or neural network algorithms. In one embodiment, the calibration step entails calibrating the sensing device using a single- or multi-point calibration, and then converting post-calibration data using correlation factors, time corrections and constants to obtain an analyte-specific value. Further signal processing can be used to refine the information obtained in the calibration step, for example, where a signal processing step is used to correct for signal differences due to variable conditions unique to the sensor element used to obtain the raw signal. In one embodiment, this further step is used to correct for signal time-dependence, particularly signal decline. In another embodiment, a constant offset term is obtained, which offset is added to the signal to account for a non-zero signal at an estimated zero analyte concentration.
Further, the methods of the present invention include enhancement of skin permeability by pricking the skin with micro-needles. In addition, the sampling system can be programed to begin execution of sampling and sensing at a defined time(s).
It is yet a further object of the invention to provide a monitoring system for continually or continuously measuring an analyte present in a biological system. The monitoring system comprises, in operative combination: (a) a sampling means for continually or continuously extracting the analyte from the biological system, (b) a sensing means in operative contact with the analyte extracted by the sampling means, and (c) a microprocessor means in operative communication with the sensing means. The sampling means is adapted for extracting the analyte across a skin or mucosal surface of a biological system. The sensing means is used to obtain a raw signal from the extracted analyte, wherein the raw signal is specifically related to the analyte. The microprocessor means is used to subject the raw signal to a conversion step, thereby converting the same into an initial signal output which is indicative of the amount of analyte extracted by the sampling means, and then perform a calibration step which correlates the initial signal output with a measurement value indicative of the concentration of analyte present in the biological system at the time of extraction. In one embodiment, the monitoring system uses iontophoresis to extract the analyte from the biological system. In other embodiments, the monitoring system is used to extract a glucose analyte from the biological system. Further, the microprocessor can be programed to begin execution of sampling and sensing at a defined time(s).
Additional objects, advantages and novel features of the invention will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art upon examination of the following, or may be learned by practice of the invention.
Before describing the present invention in detail, it is to be understood that this invention is not limited to particular compositions or biological systems as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
It must be noted that, as used in this specification and the appended claims, the singular forms “a”, “an” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to “a time-dependent variable” includes a mixture of two or more such variables, reference to “an electrochemically active species” includes two or more such species, reference to “an analyte” includes mixtures of analytes, and the like.
All publications, patents and patent applications cited herein, whether supra or infra, are hereby incorporated by reference in their entirety.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although any methods and materials similar or equivalent to those described herein can be used in the practice for testing of the present invention, the preferred materials and methods are described herein.
In describing and claiming the present invention, the following terminology will be used in accordance with the definitions set out below.
Definitions
The terms “analyte” and “target analyte” are used herein to denote any physiological analyte of interest that is a specific substance or component that is being detected and/or measured in a chemical, physical, enzymatic, or optical analysis. A detectable signal (e.g., a chemical signal or electrochemical signal) can be obtained, either directly or indirectly, from such an analyte or derivatives thereof. Furthermore, the terms “analyte” and “substance” are used interchangeably herein, and are intended to have the same meaning, and thus encompass any substance of interest. In preferred embodiments, the analyte is a physiological analyte of interest, for example, glucose, or a chemical that has a physiological action, for example, a drug or pharmacological agent.
A “sampling device” or “sampling system” refers to any device for obtaining a sample from a biological system for the purpose of determining the concentration of an analyte of interest. As used herein, the term “sampling” means invasive, minimally invasive or non-invasive extraction of a substance from the biological system, generally across a membrane such as skin or mucosa. The membrane can be natural or artificial, and can be of plant or animal nature, such as natural or artificial skin, blood vessel tissue, intestinal tissue, and the like. Typically, the sampling means are in operative contact with a “reservoir,” or “collection reservoir,” wherein the sampling means is used for extracting the analyte from the biological system into the reservoir to obtain the analyte in the reservoir. A “biological system” includes both living and artificially maintained systems. Examples of minimally invasive and noninvasive sampling techniques include iontophoresis, sonophoresis, suction, electroporation, thermal poration, passive diffusion, microfine (miniature) lances or cannulas, subcutaneous implants or insertions, and laser devices. Sonophoresis uses ultrasound to increase the permeability of the skin (see, e.g., Menon et al. (1994) Skin Pharmacology 7:130-139). Suitable sonophoresis sampling systems are described in International Publication No. WO 91/12772, published Sep. 5, 1991. Passive diffusion sampling devices are described, for example, in International Publication Nos.: WO 97/38126 (published Oct. 16, 1997); WO 97/42888, WO 97/42886, WO 97/42885, and WO 97/42882 (all published Nov. 20, 1997); and WO 97/43962 (published Nov. 27, 1997). Laser devices use a small laser beam to burn a hole through the upper layer of the patient'"'"'s skin (see, e.g., Jacques et al. (1978) J. Invest. Dermatology 88:88-93). Examples of invasive sampling techniques include traditional needle and syringe or vacuum sample tube devices.
The term “collection reservoir” is used to describe any suitable containment means for containing a sample extracted from a biological system. For example, the collection reservoir can be a receptacle containing a material which is ionically conductive (e.g., water with ions therein), or alternatively, it can be a material, such as, a sponge-like material or hydrophilic polymer, used to keep the water in place. Such collection reservoirs can be in the form of a hydrogel (for example, in the form of a disk or pad). Hydrogels are typically referred to as “collection inserts.” Other suitable collection reservoirs include, but are not limited to, tubes, vials, capillary collection devices, cannulas, and miniaturized etched, ablated or molded flow paths.
A “housing” for the sampling system can further include suitable electronics (e.g., microprocessor, memory, display and other circuit components) and power sources for operating the sampling system in an automatic fashion.
A “monitoring system,” as used herein, refers to a system useful for continually or continuously measuring a physiological analyte present in a biological system. Such a system typically includes, but is not limited to, sampling means, sensing means, and a microprocessor means in operative communication with the sampling means and the sensing means.
The term “artificial,” as used herein, refers to an aggregation of cells of monolayer thickness or greater which are grown or cultured in vivo or in vitro, and which function as a tissue of an organism but are not actually derived, or excised, from a pre-existing source or host.
The term “subject” encompasses any warm-blooded animal, particularly including a member of the class Mammalia such as, without limitation, humans and nonhuman primates such as chimpanzees and other apes and monkey species; farm animals such as cattle, sheep, pigs, goats and horses; domestic mammals such as dogs and cats; laboratory animals including rodents such as mice, rats and guinea pigs, and the like. The term does not denote a particular age or sex. Thus, adult and newborn subjects, as well as fetuses, whether male or female, are intended to be covered.
As used herein, the term “continual measurement” intends a series of two or more measurements obtained from a particular biological system, which measurements are obtained using a single device maintained in operative contact with the biological system over the time period in which the series of measurements is obtained. The term thus includes continuous measurements.
The term “transdermal,” as used herein, includes both transdermal and transmucosal techniques, i.e., extraction of a target analyte across skin or mucosal tissue. Aspects of the invention which are described herein in the context of “transdermal,” unless otherwise specified, are meant to apply to both transdermal and transmucosal techniques.
The term “transdermal extraction,” or “transdermally extracted” intends any noninvasive, or at least minimally invasive sampling method, which entails extracting and/or transporting an analyte from beneath a tissue surface across skin or mucosal tissue. The term thus includes extraction of an analyte using iontophoresis (reverse iontophoresis), electroosmosis, sonophoresis, microdialysis, suction, and passive diffusion. These methods can, of course, be coupled with application of skin penetration enhancers or skin permeability enhancing technique such as tape stripping or pricking with micro-needles. The term “transdermally extracted” also encompasses extraction techniques which employ thermal poration, electroporation, microfine lances, microfine canulas, subcutaneous implants or insertions, and the like.
The term “iontophoresis” intends a method for transporting substances across tissue by way of an application of electrical energy to the tissue. In conventional iontophoresis, a reservoir is provided at the tissue surface to serve as a container of material to be transported. Iontophoresis can be carried out using standard methods known to those of skill in the art, for example, by establishing an electrical potential using a direct current (DC) between fixed anode and cathode “iontophoretic electrodes,” alternating a direct current between anode and cathode iontophoretic electrodes, or using a more complex waveform such as applying a current with alternating polarity (AP) between iontophoretic electrodes (so that each electrode is alternately an anode or a cathode).
The term “reverse iontophoresis” refers to the movement of a substance from a biological fluid across a membrane by way of an applied electric potential or current. In reverse iontophoresis, a reservoir is provided at the tissue surface to receive the extracted material.
“Electroosmosis” refers to the movement of a substance through a membrane by way of an electric field-induced convective flow. The terms iontophoresis, reverse iontophoresis, and electroosmosis, will be used interchangeably herein to refer to movement of any ionically charged or uncharged substance across a membrane (e.g., an epithelial membrane) upon application of an electric potential to the membrane through an ionically conductive medium.
The term “sensing device,” “sensing means,” or “biosensor device” encompasses any device that can be used to measure the concentration of an analyte, or derivative thereof, of interest. Preferred sensing devices for detecting blood analytes generally include electrochemical devices and chemical devices. Examples of electrochemical devices include the Clark electrode system (see, e.g., Updike, et al., (1967) Nature 214:986-988), and other amperometric, coulometric, or potentiometric electrochemical devices. Examples of chemical devices include conventional enzyme-based reactions as used in the Lifescan® glucose monitor (Johnson and Johnson, New Brunswick, N.J.) (see, e.g., U.S. Pat. No. 4,935,346 to Phillips, et al.).
A “biosensor” or “biosensor device” includes, but is not limited to, a “sensor element” which includes, but is not limited to, a “biosensor electrode” or “sensing electrode” or “working electrode” which refers to the electrode that is monitored to determine the amount of electrical signal at a point in time or over a given time period, which signal is then correlated with the concentration of a chemical compound. The sensing electrode comprises a reactive surface which converts the analyte, or a derivative thereof, to electrical signal. The reactive surface can be comprised of any electrically conductive material such as, but not limited to, platinum-group metals (including, platinum, palladium, rhodium, ruthenium, osmium, and iridium), nickel, copper, silver, and carbon, as well as, oxides, dioxides, combinations or alloys thereof. Some catalytic materials, membranes, and fabrication technologies suitable for the construction of amperometric biosensors were described by Newman, J. D., et al. (Analytical Chemistry 67(24), 4594-4599, 1995).
The “sensor element” can include components in addition to a biosensor electrode, for example, it can include a “reference electrode,” and a “counter electrode.” The term “reference electrode” is used herein to mean an electrode that provides a reference potential, e.g., a potential can be established between a reference electrode and a working electrode. The term “counter electrode” is used herein to mean an electrode in an electrochemical circuit which acts as a current source or sink to complete the electrochemical circuit. Although it is not essential that a counter electrode be employed where a reference electrode is included in the circuit and the electrode is capable of performing the function of a counter electrode, it is preferred to have separate counter and reference electrodes because the reference potential provided by the reference electrode is most stable when it is at equilibrium. If the reference electrode is required to act further as a counter electrode, the current flowing through the reference electrode may disturb this equilibrium. Consequently, separate electrodes functioning as counter and reference electrodes are most preferred.
In one embodiment, the “counter electrode” of the “sensor element” comprises a “bimodal electrode.” The term “bimodal electrode” as used herein typically refers to an electrode which is capable of functioning non-simultaneously as, for example, both the counter electrode (of the “sensor element”) and the iontophoretic electrode (of the “sampling means”).
The terms “reactive surface,” and “reactive face” are used interchangeably herein to mean the surface of the sensing electrode that: (1) is in contact with the surface of an electrolyte containing material (e.g. gel) which contains an analyte or through which an analyte, or a derivative thereof, flows from a source thereof; (2) is comprised of a catalytic material (e.g., carbon, platinum, palladium, rhodium, ruthenium, or nickel and/or oxides, dioxides and combinations or alloys thereof) or a material that provides sites for electrochemical reaction; (3) converts a chemical signal (e.g. hydrogen peroxide) into an electrical signal (e.g., an electrical current); and (4) defines the electrode surface area that, when composed of a reactive material, is sufficient to drive the electrochemical reaction at a rate sufficient to generate a detectable, reproducibly measurable, electrical signal that is correlatable with the amount of analyte present in the electrolyte.
The term “collection reservoir” and “collection insert” are used to describe any suitable containment means for containing a sample extracted from a biological system. The reservoir can include a material which is ionically conductive (e.g., water with ions therein), wherein another material such as a sponge-like material or hydrophilic polymer is used to keep the water in place. Such collection reservoirs can be in the form of a hydrogel (for example, in the shape of a disk or pad). Other suitable collection reservoirs include, but are not limited to, tubes, vials, capillary collection devices, cannulas, and miniaturized etched, ablated or molded flow paths.
An “ionically conductive material” refers to any material that provides ionic conductivity, and through which electrochemically active species can diffuse. The ionically conductive material can be, for example, a solid, liquid, or semi-solid (e.g., in the form of a gel) material that contains an electrolyte, which can be composed primarily of water and ions (e.g., sodium chloride), and generally comprises 50% or more water by weight. The material can be in the form of a gel, a sponge or pad (e.g., soaked with an electrolytic solution), or any other material that can contain an electrolyte and allow passage therethrough of electrochemically active species, especially the analyte of interest.
The term “physiological effect” encompasses effects produced in the subject that achieve the intended purpose of a therapy. In preferred embodiments, a physiological effect means that the symptoms of the subject being treated are prevented or alleviated. For example, a physiological effect would be one that results in the prolongation of survival in a patient.
A “laminate”, as used herein, refers to structures comprised of at least two bonded layers. The layers may be bonded by welding or through the use of adhesives. Examples of welding include, but are not limited to, the following: ultrasonic welding, heat bonding, and inductively coupled localized heating followed by localized flow. Examples of common adhesives include, but are not limited to, pressure sensitive adhesives, thermoset adhesives, cyanocrylate adhesives, epoxies, contact adhesives, and heat sensitive adhesives.
A “collection assembly”, as used herein, refers to structures comprised of several layers, where the assembly includes at least one collection insert, for example a hydrogel. An example of a collection assembly of the present invention is a mask layer, collection inserts, and a retaining layer where the layers are held in appropriate, functional relationship to each other but are not necessarily a laminate, i.e., the layers may not be bonded together. The layers may, for example, be held together by interlocking geometry or friction.
An “autosensor assembly”, as used herein, refers to structures generally comprising a mask layer, collection inserts, a retaining layer, an electrode assembly, and a support tray. The autosensor assembly may also include liners. The layers of the assembly are held in appropriate, functional relationship to each other.
The mask and retaining layers are preferably composed of materials that are substantially impermeable to the analyte (chemical signal) to be detected (e.g., glucose); however, the material can be permeable to other substances. By “substantially impermeable” is meant that the material reduces or eliminates chemical signal transport (e.g., by diffusion). The material can allow for a low level of chemical signal transport, with the proviso that chemical signal that passes through the material does not cause significant edge effects at the sensing electrode.
“Substantially planar” as used herein, includes a planar surface that contacts a slightly curved surface, for example, a forearm or upper arm of a subject. A “substantially planar” surface is, for example, a surface having a shape to which skin can conform, i.e., contacting contact between the skin and the surface.
By the term “printed” as used herein is meant a substantially uniform deposition of an electrode formulation onto one surface of a substrate (i.e., the base support). It will be appreciated by those skilled in the art that a variety of techniques may be used to effect substantially uniform deposition of a material onto a substrate, e.g., Gravure-type printing, extrusion coating, screen coating, spraying, painting, or the like.
The term “enzyme” intends any compound or material which catalyzes a reaction between molecules to produce one or more reaction products. The term thus includes protein enzymes, or enzymatically active portions (fragments) thereof, which proteins and/or protein fragments may be isolated from a natural source, or recombinantly or synthetically produced. The term also encompasses designed synthetic enzyme mimetics.
The term “time-dependent signal decline” refers to a detectable decrease in measured signal over time when no decrease or change in analyte concentration is actually occurring. The decrease in signal over time may be due to a number of different phenomena.
The term “signal-to-noise ratio” describes the relationship between the actual signal intended to be measured and the variation in signal in the absence of the analyte. The terms “S/N” and “SNR” are also used to refer to the signal-to-noise ratio. “Noise,” as used herein, refers to any undesirable signal which is measured along with the intended signal.
General Methods
The present invention relates to use of a device for transdermally extracting and measuring the concentration of a target analyte present in a biological system. In preferred embodiments, the sensing device comprises a biosensor. In other preferred embodiments, a sampling device is used to extract small amounts of a target analyte from the biological system, and then sense and/or quantify the concentration of the target analyte. Measurement with the biosensor and/or sampling with the sampling device can be carried out in a continual or continuous manner. Continual or continuous measurements allow for closer monitoring of target analyte concentration fluctuations.
The analyte can be any specific substance or component that one is desirous of detecting and/or measuring in a chemical, physical, enzymatic, or optical analysis. Such analytes include, but are not limited to, amino acids, enzyme substrates or products indicating a disease state or condition, other markers of disease states or conditions, drugs of abuse, therapeutic and/or pharmacologic agents (e.g., theophylline, anti-HIV drugs, lithium, anti-epileptic drugs, cyclosporin, chemotherapeutics), electrolytes, physiological analytes of interest (e.g., urate/uric acid, carbonate, calcium, potassium, sodium, chloride, bicarbonate (CO2), glucose, urea (blood urea nitrogen) lactate/lactic acid, hydroxybutyrate, cholesterol, triglycerides, creatine, creatinine, insulin, hematocrit, and hemoglobin), blood gases (carbon dioxide, oxygen, pH), lipids, heavy metals (e.g., lead, copper), and the like. In preferred embodiments, the analyte is a physiological analyte of interest, for example glucose, or a chemical that has a physiological action, for example a drug or pharmacological agent.
In order to facilitate detection of the analyte, an enzyme can be disposed in the collection reservoir, or, if several collection reservoirs are used, the enzyme can be disposed in several or all of the reservoirs. The selected enzyme is capable of catalyzing a reaction with the extracted analyte (in this case glucose) to the extent that a product of this reaction can be sensed, e.g., can be detected electrochemically from the generation of a current which current is detectable and proportional to the concentration or amount of the analyte which is reacted. A suitable enzyme is glucose oxidase which oxidizes glucose to gluconic acid and hydrogen peroxide. The subsequent detection of hydrogen peroxide on an appropriate biosensor electrode generates two electrons per hydrogen peroxide molecule which create a current which can be detected and related to the amount of glucose entering the device. Glucose oxidase (GOx) is readily available commercially and has well known catalytic characteristics. However, other enzymes can also be used, so long as they specifically catalyze a reaction with an analyte or substance of interest to generate a detectable product in proportion to the amount of analyte so reacted.
In like manner, a number of other analyte-specific enzyme systems can be used in the invention, which enzyme systems operate on much the same general techniques. For example, a biosensor electrode that detects hydrogen peroxide can be used to detect ethanol using an alcohol oxidase enzyme system, or similarly uric acid with urate oxidase system, urea with a urease system, cholesterol with a cholesterol oxidase system, and theophylline with a xanthine oxidase system.
In addition, the oxidase enzyme (used for hydrogen peroxide-based detection) can be replaced with another redox system, for example, the dehydrogenase-enzyme NAD-NADH, which offers a separate route to detecting additional analytes. Dehydrogenase-based sensors can use working electrodes made of gold or carbon (via mediated chemistry). Examples of analytes suitable for this type of monitoring include, but are not limited to, cholesterol, ethanol, hydroxybutyrate, phenylalanine, triglycerides, and urea. Further, the enzyme can be eliminated and detection can rely on direct electrochemical or potentiometric detection of an analyte. Such analytes include, without limitation, heavy metals (e.g., cobalt, iron, lead, nickel, zinc), oxygen, carbonate/carbon dioxide, chloride, fluoride, lithium, pH, potassium, sodium, and urea. Also, the sampling system described herein can be used for therapeutic drug monitoring, for example, monitoring anti-epileptic drugs (e.g., phenytion), chemotherapy (e.g., adriamycin), hyperactivity (e.g., ritalin), and anti-organ-rejection (e.g., cyclosporin).
The methods for measuring the concentration of a target analyte can be generalized as follows. An initial step (Step A) entails obtaining a raw signal from a sensing device, which signal is related to a target analyte present in the biological system. The raw signal can be obtained using any suitable sensing methodology including, for example, methods which rely on direct contact of a sensing apparatus with the biological system; methods which extract samples from the biological system by invasive, minimally invasive, and non-invasive sampling techniques, wherein the sensing apparatus is contacted with the extracted sample; methods which rely on indirect contact of a sensing apparatus with the biological system; and the like. In preferred embodiments of the invention, methods are used to extract samples from the biological sample using minimally invasive or non-invasive sampling techniques. The sensing apparatus used with any of the above-noted methods can employ any suitable sensing element to provide the signal including, but not limited to, physical, chemical, electrochemical, photochemical, spectrophotometric, polarimetric, colorimetric, radiometric, or like elements. In preferred embodiments of the invention, a biosensor is used which comprises an electrochemical sensing element.
After the raw signal has been obtained, the signal can undergo a data screening method (Step B) in order to eliminate outlier signals and/or poor (incorrect) signals using a predefined set of selection criteria. In addition, or alternatively, the raw signal can be converted in a conversion step (Step C) which can (i) remove or correct for background information, (ii) integrate the signal over a sensing time period, (iii) perform any process which converts the signal from one signal type to another, or (iv) perform any combination of steps (i), (ii) and/or (iii). In preferred embodiments, the conversion step entails a baseline background subtraction method to remove background from the raw signal and an integration step. In other embodiments, the conversion step can be tailored for use with a sensing device that provides both active and reference (blank) signals; wherein mathematical transformations are used to individually smooth active and reference signals, and/or to subtract a weighted reference (blank) signal from the active signal. In still further embodiments, the conversion step includes correction functions which account for changing conditions in the biological system and/or the biosensor system (e.g., temperature fluctuations in the biological system, temperature fluctuations in the sensor element, skin conductivity fluctuations, or combinations thereof). The result of the conversion step is an initial signal output which provides a value which can be correlated with the concentration of the target analyte in the biological sample.
In a calibration step (Step D), the raw signal obtained from Step A, or the initial signal obtained from Step B and/or Step C, is converted into an analyte-specific value of known units to provide an interpretation of the signal obtained from the sensing device. The interpretation uses a one-to-one mathematical transformation to model the relationship between a measured response in the sensing device and a corresponding analyte-specific value. Thus, the calibration step is used herein to relate, for example, an electrochemical signal (detected by a biosensor) with the concentration of a target analyte in a biological system. In one embodiment, the calibration step entails calibrating the sensing device using a single- or multi-point calibration, and then converting post-calibration data using correlation factors, time corrections and constants to obtain an analyte-specific value. Further signal processing can be used to refine the information obtained in the calibration step, for example, where a signal processing step is used to correct for signal differences due to variable conditions unique to the sensor element used to obtain the raw signal. In one embodiment, this further step is used to correct for signal time-dependence, particularly signal decline. In another embodiment, a constant offset term is obtained, which offset is added to the signal to account for a non-zero signal at an estimated zero analyte concentration.
The analyte value obtained using the above techniques can optionally be used in a subsequent step (Step E) to predict future (time forecasting) or past (calibration) measurements of the target analyte concentration in the biological system. For example, a series of analyte values are obtained by performing any combination of Steps A, B, C, and/or D in an iterative manner. This measurement series is then used to predict unmeasured analyte values at different points in time, future or past. In this manner, lag times inherent in certain sampling and/or sensing techniques can be reduced or eliminated to provide real time measurement predictions.
In another optional step, analyte values obtained using the above techniques can be used in a subsequent step (Step F) to control an aspect of the biological system. In one embodiment, the analyte value obtained in Step D is used to determine when, and at what level, a constituent should be added to the biological system in order to control an aspect of the biological system. In a preferred embodiment, the analyte value can be used in a feedback control loop to control a physiological effect in the biological system.
The above general methods (Steps A through F) are each independently useful in analyte sensing systems and can, of course, be used in a wide variety of combinations selected for a particular biological system, target analyte, and/or sensing technique. For example, in certain applications, a measurement sequence can include Steps A, C, D, E and F, in other applications, a measurement sequence can include Steps A, B, C and D, and the like. The determination of particularly suitable combinations is within the skill of the ordinarily skilled artisan when directed by the instant disclosure. Furthermore, Steps C through F are preferably embodied as one or more mathematical functions as described herein below. These functions can thus be carried out using a microprocessor in a monitoring system. Although these methods are broadly applicable to measuring any chemical analyte and/or substance in a biological system, the invention is expressly exemplified for use in a non-invasive, transdermal sampling system which uses an electrochemical biosensor to quantify or qualify glucose or a glucose metabolite.
Step A: Obtaining the Raw Signal.
The raw signal can be obtained using any sensing device that is operatively contacted with the biological system. Such sensing devices can employ physical, chemical, electrochemical, spectrophotometric, polarimetric, calorimetric, radiometric, or like measurement techniques. In addition, the sensing device can be in direct or indirect contact with the biological system, or used with a sampling device which extracts samples from the biological system using invasive, minimally invasive or non-invasive sampling techniques. In preferred embodiments, a minimally invasive or non-invasive sampling device is used to obtain samples from the biological system, and the sensing device comprises a biosensor with an electrochemical sensing element. In particularly preferred embodiments, a sampling device is used to obtain continual transdermal or transmucosal samples from a biological system, and the analyte of interest is glucose.
More specifically, a non-invasive glucose monitoring device is used to measure changes in glucose levels in an animal subject over a wide range of glucose concentrations. The sampling method is based on transdermal glucose extraction and the sensing method is based on electrochemical detection technology. The device can be contacted with the biological system continuously, and automatically obtains glucose samples in order to measure glucose concentration at preprogrammed intervals.
Sampling is carried out continually by non-invasively extracting glucose through the skin of the patient. More particularly, an iontophoretic current is applied to a surface of the skin of a subject. When the current is applied, ions or charged molecules pull along other uncharged molecules or particles such as glucose which are drawn into a collection reservoir placed on the surface of the skin. The collection reservoir may comprise any ionically conductive material and is preferably in the form of a hydrogel which is comprised of a hydrophilic material, water and an electrolyte.
The collection reservoir may further contain an enzyme which catalyzes a reaction of glucose to form an easily detectable species. The enzyme is preferably glucose oxidase (GOx) which catalyzes the reaction between glucose and oxygen and results in the production of hydrogen peroxide. The hydrogen peroxide reacts at a catalytic surface of a biosensor electrode, resulting in the generation of electrons which create a detectable biosensor current (raw signal). Based on the amount of biosensor current created over a given period of time, a measurement is taken, which measurement is related to the amount of glucose drawn into the collection reservoir over a given period of time. In a preferred embodiment, the reaction is allowed to continue until substantially all of the glucose in the collection reservoir has been subjected to a reaction and is therefore no longer detectable, and the biosensor current generated is related to the concentration of glucose in the subject at the approximate time of sample collection.
When the reaction is complete, the process is repeated and a subsequent measurement is obtained. More specifically, the iontophoretic current is again applied, glucose is drawn through the skin surface into the collection reservoir, and the reaction is catalyzed in order to create a biosensor current. These sampling (extraction) and sensing operations are integrated such that glucose is extracted into the hydrogel collection pad where it contacts the GOx enzyme. The GOx enzyme converts glucose and oxygen in the hydrogel to hydrogen peroxide which diffuses to the sensor and is catalyzed by the sensor to regenerate oxygen and form electrons. The electrons generate an electrical signal that can be measured, analyzed, and correlated to blood glucose.
Optionally, one or more additional “active” collection reservoirs (each containing the GOx enzyme) can be used to obtain measurements. In one embodiment, two active collection reservoirs are used, and an average is taken between signals from the reservoirs for each measurement time point. Obtaining multiple signals, and then averaging reads from each signals, allows for signal smoothing of unusual data points from a sensor that otherwise may not have been detected by data screening techniques. Furthermore, skin site variability can be detected, and “lag” and/or “lead” differences in blood glucose changes relative to extracted glucose changes can be mitigated. In another embodiment, a second collection reservoir can be provided which does not contain the GOx enzyme. This second reservoir can serve as an internal reference (blank) for the sensing device, where a biosensor is used to measure the “blank” signal from the reference reservoir which signal is then used in a blank subtraction step as described below.
A generalized method for continual monitoring of a physiological analyte is disclosed in International Publication No. WO 97/24059, published Jul. 10, 1997, which publication is incorporated herein by reference. As noted in that publication, the analyte is extracted into a reservoir containing a hydrogel which is preferably comprised of a hydrophilic material of the type described in International Publication No. WO 97/02811, published Jan. 30, 1997, which publication is incorporated herein by reference. Suitable hydrogel materials include polyethylene oxide, polyacrylic acid, polyvinylalcohol and related hydrophilic polymeric materials combined with water to form an aqueous gel.
In the above non-invasive glucose monitoring device, a biosensor electrode is positioned on a surface of the hydrogel opposite the surface contacting the skin. The sensor electrode acts as a detector which detects current generated by hydrogen peroxide in the redox reaction, or more specifically detects current which is generated by the electrons generated by the redox reaction catalyzed by the platinum surface of the electrode. The details of such electrode assemblies and devices for iontophoretic extraction of glucose are disclosed in International Publication No. WO 96/00110, published Jan. 4, 1996, and International Publication No. WO 97/10499, published Mar. 2, 1997, which publications are also incorporated herein by reference.
Referring now to
Referring now to
In one embodiment, the electrode assemblies can include bimodal electrodes as shown in
Referring now to
In one embodiment, the electrode assemblies can include bimodal electrodes as shown in
The components described herein are intended for use in a automatic sampling device which is configured to be worn like an ordinary wristwatch. As described in International Publication No. WO 96/00110, published Jan. 4, 1996, the wristwatch housing (not shown) contains conductive leads which communicate with the iontophoretic electrodes and the biosensor electrodes to control cycling and provide power to the iontophoretic electrodes, and to detect electrochemical signals produced at the biosensor electrode surfaces. The wristwatch housing can further include suitable electronics (e.g., microprocessor, memory, display and other circuit components) and power sources for operating the automatic sampling system.
Modifications and additions to the embodiment of
A power source (e.g., one or more rechargeable or nonrechargeable batteries) can be disposed within the housing 32 or within the straps 34 which hold the device in contact with a skin or mucosal surface of a subject. In use, an electric potential (either direct current or a more complex waveform) is applied between the two iontophoretic electrodes 12 and 14 such that current flows from the first iontophoretic electrode 12, through the first conductive medium 8 into the skin or mucosal surface, and then back out through the second conductive medium 10 to the second iontophoretic electrode 14. The current flow is sufficient to extract substances including an analyte of interest through the skin into one or both of collection reservoirs 4 and 6. The electric potential may be applied using any suitable technique, for example, the applied current density may be in the range of about 0.01 to 0.5 mA/cm2. In a preferred embodiment, the device is used for continual or continuous monitoring, and the polarity of iontophoretic electrodes 12 and 14 is alternated at a rate of about one switch every 10 seconds to about one switch every hour so that each electrode is alternately a cathode or an anode. The housing 32 can further include an optional temperature sensing element (e.g., a thermistor, thermometer, or thermocouple device) which monitors the temperature at the collection reservoirs to enable temperature correction of sensor signals as described in detail below. The housing can also include an optional conductance sensing element (e.g., an integrated pair of electrodes) which monitors conductance at the skin or mucosal surface to enable data screening correction or invalidation of sensor signals as also described in detail below.
After a suitable iontophoretic extraction period, one or both of the sensor electrode sets can be activated in order to detect extracted substances including the analyte of interest. Operation of the iontophoretic sampling device 30 is controlled by a controller 36 (e.g., a microprocessor), which interfaces with the iontophoretic electrodes, the sensor electrodes, the power supply, the optional temperature and/or conductance sensing elements, a display and other electronics. For example, the, controller 36 can include a programmable a controlled circuit source/sink drive for driving the iontophoretic electrodes. Power and reference voltage are provided to the sensor electrodes, and signal amplifiers can be used to process the signal from the working electrode or electrodes. In general, the controller discontinues the iontophoretic current drive during sensing periods. A sensor confidence loop can be provided for continually monitoring the sampling system to insure proper operations.
In a further aspect, the sampling device can operate in an alternating polarity mode using first and second bimodal electrodes (
The reference (
The general operation of an iontophoretic sampling system is the cyclical repetition of two phases: (1) a reverse-iontophoretic phase, followed by a (2) sensing phase. During the reverse iontophoretic phase, the first bimodal electrode (